Skip to main content
. 2016 Apr 21;7(25):37566–37580. doi: 10.18632/oncotarget.8885

Table 4. Correlation of the mutation rate and variants frequency of top-4 mutated genes stratified by tumor AJCC stage and tumor location.

AJCC stage Tumor location
Stage 0-II Stage III-IV p value Rectum Left Right p value
n=30 n=20 n=15 n=21 n=14
Total genes Tumor with mutation (%) 90 85 0.594 93.3 85.7 85.7 0.749
Variants frequency (%) 40.2 ± 18.74 32 ± 20.4 0.046 33 ± 16.8 37.6 ± 19.0 40 ± 22.7 0.226
TP53 Tumor with mutation (%) 33.3 65 0.027 53.3 42.8 42.8 0.793
Variants frequency (%) 42.7 ± 18.8 41 ± 20.8 0.815 32 ± 12.5 48.4 ± 18.8 43 ± 24.9 0.239
KRAS Tumor with mutation (%) 46.6 40 0.641 53.3 47.6 28.5 0.369
Variants frequency (%) 42 ± 15.7 38 ± 25.4 0.692 31.9 ± 12.5 38 ± 17.6 62 ± 21.6 0.025
APC Tumor with mutation (%) 30 40 0.464 53.3 14.2 35.7 0.043
Variants frequency (%) 41.5 ± 20.1 35.1 ± 25.7 0.638 39.6 ± 24.4 25.6 ± 11.6 45.16 ± 20.8 0.421
PIK3CA Tumor with mutation (%) 23.3 25 0.892 13.3 19 42.8 0.139
Variants frequency (%) 31.8 ± 8.67 21.5 ± 5.9 0.031 29.5 ± 7.8 25.7 ± 8.3 27.7 ± 10.9 0.902